Media Releases
Ypsomed and CamDiab launch myLoop on iOS
‘‘The introduction of the iOS version of the myLoop solution is an important step towards the wider availability of AID solutions for the treatment management of type 1 diabetes,’’
explains Sébastien Delarive, Chief Executive Officer of mylife Diabetes Care.
‘‘The expansion of the CamAPS FX app to iOS represents a major milestone in making automated insulin delivery more accessible to people with type 1 diabetes. Our goal is to provide a seamless, user-friendly experience that empowers individuals to better manage their condition with greater flexibility and convenience, ’’
says Prof. Roman Hovorka, Director CamDiab Ltd.
Pilot launch in Sweden, followed by a broad rollout
During the pilot phase in Sweden, myLoop will initially be available with the FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors from Abbott. The integration of the Dexcom G6 sensor into the CamAPS FX app will follow. After the successful pilot launch, the rollout of myLoop on iOS will continue across Europe followed by Australia and Canada throughout 2025.
Further information and details about the CamAPS FX app can be found at www.mylife-diabetes-care.com/loop.